CN103990221A - 一种药物洗脱球囊装置 - Google Patents
一种药物洗脱球囊装置 Download PDFInfo
- Publication number
- CN103990221A CN103990221A CN201310053627.9A CN201310053627A CN103990221A CN 103990221 A CN103990221 A CN 103990221A CN 201310053627 A CN201310053627 A CN 201310053627A CN 103990221 A CN103990221 A CN 103990221A
- Authority
- CN
- China
- Prior art keywords
- medicine
- balloon
- layer
- polymer
- polymeric layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 170
- 238000010828 elution Methods 0.000 title claims abstract description 33
- 229940079593 drug Drugs 0.000 title claims description 28
- 229920000642 polymer Polymers 0.000 claims abstract description 44
- 239000000654 additive Substances 0.000 claims abstract description 16
- 230000000996 additive effect Effects 0.000 claims abstract description 13
- 230000003902 lesion Effects 0.000 claims abstract description 7
- 239000013047 polymeric layer Substances 0.000 claims description 44
- 239000010410 layer Substances 0.000 claims description 34
- 210000004204 blood vessel Anatomy 0.000 claims description 23
- 229920002988 biodegradable polymer Polymers 0.000 claims description 20
- 239000004621 biodegradable polymer Substances 0.000 claims description 20
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 229930012538 Paclitaxel Natural products 0.000 claims description 5
- -1 biogum Chemical compound 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 229920000554 ionomer Polymers 0.000 claims description 5
- 229960001592 paclitaxel Drugs 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 4
- 239000004626 polylactic acid Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 239000003146 anticoagulant agent Substances 0.000 claims description 3
- 230000017531 blood circulation Effects 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- RBMHUYBJIYNRLY-UHFFFAOYSA-N 2-[(1-carboxy-1-hydroxyethyl)-hydroxyphosphoryl]-2-hydroxypropanoic acid Chemical compound OC(=O)C(O)(C)P(O)(=O)C(C)(O)C(O)=O RBMHUYBJIYNRLY-UHFFFAOYSA-N 0.000 claims description 2
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 2
- 229920002683 Glycosaminoglycan Chemical class 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 229920002732 Polyanhydride Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 150000001408 amides Chemical group 0.000 claims description 2
- 229940127219 anticoagulant drug Drugs 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 238000010382 chemical cross-linking Methods 0.000 claims description 2
- 239000011247 coating layer Substances 0.000 claims description 2
- 239000003431 cross linking reagent Substances 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 229960003444 immunosuppressant agent Drugs 0.000 claims description 2
- 230000001861 immunosuppressant effect Effects 0.000 claims description 2
- 239000003018 immunosuppressive agent Substances 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 238000011275 oncology therapy Methods 0.000 claims description 2
- 150000003891 oxalate salts Chemical class 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 229920001434 poly(D-lactide) Polymers 0.000 claims description 2
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims description 2
- 150000004804 polysaccharides Polymers 0.000 claims description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 2
- 229960002930 sirolimus Drugs 0.000 claims description 2
- 235000010487 tragacanth Nutrition 0.000 claims description 2
- 239000000196 tragacanth Substances 0.000 claims description 2
- 229940116362 tragacanth Drugs 0.000 claims description 2
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 239000002344 surface layer Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 21
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 2
- 229920000299 Nylon 12 Polymers 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 210000003606 umbilical vein Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 101100364675 Mus musculus Ss18l2 gene Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229920006222 acrylic ester polymer Polymers 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 1
- 229960002603 iopromide Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1075—Balloon catheters with special features or adapted for special applications having a balloon composed of several layers, e.g. by coating or embedding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310053627.9A CN103990221B (zh) | 2013-02-19 | 2013-02-19 | 一种药物洗脱球囊装置 |
PCT/CN2014/072264 WO2014127718A1 (zh) | 2013-02-19 | 2014-02-19 | 一种药物洗脱球囊装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310053627.9A CN103990221B (zh) | 2013-02-19 | 2013-02-19 | 一种药物洗脱球囊装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103990221A true CN103990221A (zh) | 2014-08-20 |
CN103990221B CN103990221B (zh) | 2017-08-25 |
Family
ID=51304711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310053627.9A Active CN103990221B (zh) | 2013-02-19 | 2013-02-19 | 一种药物洗脱球囊装置 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103990221B (zh) |
WO (1) | WO2014127718A1 (zh) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104511084A (zh) * | 2014-12-30 | 2015-04-15 | 深圳市信立泰生物医疗工程有限公司 | 一种球囊导管 |
CN105498074A (zh) * | 2015-12-25 | 2016-04-20 | 李雷 | 血管壁修复系统 |
CN107261300A (zh) * | 2016-04-04 | 2017-10-20 | 美敦力心血管股份有限公司 | 球囊导管以及用于覆盖医疗球囊的方法 |
CN108339159A (zh) * | 2017-01-24 | 2018-07-31 | 青岛智辰生物科技有限公司 | 一种药物涂层及其制备方法 |
CN109260526A (zh) * | 2018-08-21 | 2019-01-25 | 陈绍良 | 小檗碱洗脱球囊赋形液及其应用 |
CN110087703A (zh) * | 2016-12-20 | 2019-08-02 | 苏尔莫迪克斯公司 | 从亲水性聚醚嵌段酰胺共聚物表面递送疏水性活性剂 |
CN110141760A (zh) * | 2019-06-05 | 2019-08-20 | 山东百多安医疗器械有限公司 | 一种表面载药的椎体成形扩张球囊及其制备方法 |
CN110292701A (zh) * | 2019-06-27 | 2019-10-01 | 山东瑞安泰医疗技术有限公司 | 一种药物洗脱球囊导管及其制备方法 |
WO2020103667A1 (zh) * | 2018-11-23 | 2020-05-28 | 上海微创医疗器械(集团)有限公司 | 药物洗脱球囊和球囊导管 |
CN112805042A (zh) * | 2018-09-19 | 2021-05-14 | 亚历山大·卢本 | 球囊导管球囊的活性物质涂层 |
CN113975594A (zh) * | 2020-11-19 | 2022-01-28 | 上海申淇医疗科技有限公司 | 一种药物涂层球囊及其制备方法 |
US11246963B2 (en) | 2012-11-05 | 2022-02-15 | Surmodics, Inc. | Compositions and methods for delivery of hydrophobic active agents |
US11529440B2 (en) | 2011-05-20 | 2022-12-20 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
CN115999024A (zh) * | 2023-03-24 | 2023-04-25 | 上海佳沐垚医疗科技有限公司 | 一种药物释放控制装置 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10792477B2 (en) | 2016-02-08 | 2020-10-06 | Orbusneich Medical Pte. Ltd. | Drug eluting balloon |
CN109985280B (zh) * | 2017-12-29 | 2022-06-21 | 先健科技(深圳)有限公司 | 药物球囊及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1917920A (zh) * | 2003-11-14 | 2007-02-21 | Cytyc公司 | 药物洗脱近接治疗方法和装置 |
CN101589971A (zh) * | 2009-06-30 | 2009-12-02 | 北京中孵友信医药科技有限公司 | 第三代pci治疗性球囊支架系统、制备方法及应用 |
CN102526861A (zh) * | 2010-12-27 | 2012-07-04 | 微创医疗器械(上海)有限公司 | 一种介入医疗器械 |
CN102883753A (zh) * | 2010-03-25 | 2013-01-16 | 路通医疗股份有限公司 | 用于医疗设备的释药涂层 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN201006050Y (zh) * | 2006-10-18 | 2008-01-16 | 北京乐普医疗器械有限公司 | 可生物降解高分子载药涂层心血管支架 |
JP5767226B2 (ja) * | 2009-08-27 | 2015-08-19 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 医療用デバイス |
-
2013
- 2013-02-19 CN CN201310053627.9A patent/CN103990221B/zh active Active
-
2014
- 2014-02-19 WO PCT/CN2014/072264 patent/WO2014127718A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1917920A (zh) * | 2003-11-14 | 2007-02-21 | Cytyc公司 | 药物洗脱近接治疗方法和装置 |
CN101589971A (zh) * | 2009-06-30 | 2009-12-02 | 北京中孵友信医药科技有限公司 | 第三代pci治疗性球囊支架系统、制备方法及应用 |
CN102883753A (zh) * | 2010-03-25 | 2013-01-16 | 路通医疗股份有限公司 | 用于医疗设备的释药涂层 |
CN102526861A (zh) * | 2010-12-27 | 2012-07-04 | 微创医疗器械(上海)有限公司 | 一种介入医疗器械 |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11529440B2 (en) | 2011-05-20 | 2022-12-20 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
US12083249B2 (en) | 2011-05-20 | 2024-09-10 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
US11246963B2 (en) | 2012-11-05 | 2022-02-15 | Surmodics, Inc. | Compositions and methods for delivery of hydrophobic active agents |
CN104511084A (zh) * | 2014-12-30 | 2015-04-15 | 深圳市信立泰生物医疗工程有限公司 | 一种球囊导管 |
CN105498074B (zh) * | 2015-12-25 | 2017-08-08 | 李雷 | 血管壁修复系统 |
WO2017107632A1 (zh) * | 2015-12-25 | 2017-06-29 | 李雷 | 血管壁修复系统 |
CN105498074A (zh) * | 2015-12-25 | 2016-04-20 | 李雷 | 血管壁修复系统 |
CN107261300A (zh) * | 2016-04-04 | 2017-10-20 | 美敦力心血管股份有限公司 | 球囊导管以及用于覆盖医疗球囊的方法 |
CN110087703A (zh) * | 2016-12-20 | 2019-08-02 | 苏尔莫迪克斯公司 | 从亲水性聚醚嵌段酰胺共聚物表面递送疏水性活性剂 |
CN108339159A (zh) * | 2017-01-24 | 2018-07-31 | 青岛智辰生物科技有限公司 | 一种药物涂层及其制备方法 |
CN109260526A (zh) * | 2018-08-21 | 2019-01-25 | 陈绍良 | 小檗碱洗脱球囊赋形液及其应用 |
CN112805042A (zh) * | 2018-09-19 | 2021-05-14 | 亚历山大·卢本 | 球囊导管球囊的活性物质涂层 |
WO2020103667A1 (zh) * | 2018-11-23 | 2020-05-28 | 上海微创医疗器械(集团)有限公司 | 药物洗脱球囊和球囊导管 |
CN110141760A (zh) * | 2019-06-05 | 2019-08-20 | 山东百多安医疗器械有限公司 | 一种表面载药的椎体成形扩张球囊及其制备方法 |
CN110141760B (zh) * | 2019-06-05 | 2021-10-08 | 山东百多安医疗器械股份有限公司 | 一种表面载药的椎体成形扩张球囊及其制备方法 |
CN110292701B (zh) * | 2019-06-27 | 2021-11-16 | 山东瑞安泰医疗技术有限公司 | 一种药物洗脱球囊导管及其制备方法 |
CN110292701A (zh) * | 2019-06-27 | 2019-10-01 | 山东瑞安泰医疗技术有限公司 | 一种药物洗脱球囊导管及其制备方法 |
CN113975594A (zh) * | 2020-11-19 | 2022-01-28 | 上海申淇医疗科技有限公司 | 一种药物涂层球囊及其制备方法 |
CN115999024A (zh) * | 2023-03-24 | 2023-04-25 | 上海佳沐垚医疗科技有限公司 | 一种药物释放控制装置 |
Also Published As
Publication number | Publication date |
---|---|
CN103990221B (zh) | 2017-08-25 |
WO2014127718A1 (zh) | 2014-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103990221A (zh) | 一种药物洗脱球囊装置 | |
US10058636B2 (en) | Drug coated balloon catheter | |
CN104623740B (zh) | 一种药物球囊及其制备方法 | |
US10695542B2 (en) | Drug coated balloon | |
CN102258811B (zh) | 持久使血管开的活性物释放医药产品的制造、方法和使用 | |
CN103948975B (zh) | 一种靶向药物释放介入类医疗器械及其制备方法 | |
US8128951B2 (en) | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens | |
CN101869514B (zh) | 用于治疗冠状动脉狭窄的支架 | |
CN110201243B (zh) | 一种复合药物涂层球囊导管及其制备方法 | |
CN104174074A (zh) | 一种药物涂层组合物、其制备方法及利用其制成的植入或介入医疗器械 | |
CA2942795A1 (en) | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens | |
CN204050424U (zh) | 一种药物球囊 | |
N Mengatto et al. | Recent advances in chitosan films for controlled release of drugs | |
CN106073942A (zh) | 一种支架及药物输送装置 | |
CN101365447A (zh) | 用于治疗再狭窄病变的含有纳米粒子的药物组合物 | |
WO2013152713A1 (zh) | 一种基于氢键作用的药物球囊及其涂层方法 | |
CN108339159B (zh) | 一种药物涂层及其制备方法 | |
CN103830778A (zh) | 一种含有聚电解质的药物涂层及其制备方法 | |
CN111214748A (zh) | 药物洗脱球囊和球囊导管 | |
CN204219578U (zh) | 含沙利度胺层的血管内涂层球囊 | |
CN101309706A (zh) | 药剂释放控制组合物及药剂释放性医疗器具 | |
CN111970999A (zh) | 一种减少血管平滑肌细胞增殖的方法及装置 | |
CN201543095U (zh) | 药物涂层球囊 | |
US20240226509A1 (en) | Drug balloon catheter capable of controlling drug release and use thereof | |
CN116440332A (zh) | 可降解胰胆管支架 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MICROPORT ENDOVASCULAR (SHANGHAI) CO., LTD. Free format text: FORMER OWNER: SHANGHAI MICROPORT MEDICAL EQUIPMENT (GROUP) CO., LTD. Effective date: 20141021 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 PUDONG NEW AREA, SHANGHAI TO: 201318 PUDONG NEW AREA, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141021 Address after: 201318 Pudong New Area Kang Xin Road, Lane 3399, Lane 1, No. Applicant after: MICROPORT ENDOVASCULAR (SHANGHAI) Co.,Ltd. Address before: 201203 Shanghai City Newton Road, Pudong New Area Zhangjiang hi tech Park No. 501 Applicant before: SHANGHAI MICROPORT MEDICAL (GROUP) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 3399 Lane 1, Kangxin Highway, Pudong New District, Shanghai, 201318 Patentee after: SHANGHAI MICROPORT ENDOVASCULAR MEDTECH Co.,Ltd. Address before: No. 3399 Lane 1, Kangxin Highway, Pudong New District, Shanghai, 201318 Patentee before: MICROPORT ENDOVASCULAR (SHANGHAI) Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 3399 Lane 1, Kangxin Highway, Pudong New District, Shanghai, 201321 Patentee after: Shanghai minimally invasive heart pulse medical technology (Group) Co.,Ltd. Address before: No. 3399 Lane 1, Kangxin Highway, Pudong New District, Shanghai, 201318 Patentee before: SHANGHAI MICROPORT ENDOVASCULAR MEDTECH Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210222 Address after: Room 101, No.1, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, 201321 Patentee after: Shanghai Hongmai Medical Technology Co.,Ltd. Address before: No. 3399 Lane 1, Kangxin Highway, Pudong New District, Shanghai, 201321 Patentee before: Shanghai minimally invasive heart pulse medical technology (Group) Co.,Ltd. |
|
TR01 | Transfer of patent right |